Issue 2/2018
Content (12 Articles)
The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach
Grégoire de Lagasnerie, Anne-Sophie Aguadé, Pierre Denis, Anne Fagot-Campagna, Christelle Gastaldi-Menager
Improving risk equalization using information on physiotherapy diagnoses
Frank Eijkenaar, René C. J. A. van Vliet
The impact of physician-level drug budgets on prescribing behavior
Katharina Elisabeth Fischer, Taika Koch, Karel Kostev, Tom Stargardt
The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany
Klaus Kaier, Holger Reinecke, Huseyin Naci, Lutz Frankenstein, Martin Bode, Werner Vach, Philip Hehn, Andreas Zirlik, Manfred Zehender, Jochen Reinöhl
Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
Michele R. Wilson, Annika Bergman, Helene Chevrou-Severac, Ross Selby, Michael Smyth, Matthew C. Kerrigan
Systematic review of model-based economic evaluations of heart valve implantations
Simone A. Huygens, Johanna. J. M. Takkenberg, Maureen P. M. H. Rutten-van Mölken
Association between cultural distance and migrant self-rated health
Jens Detollenaere, Stijn Baert, Sara Willems
Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies
Erik Nord
New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year
Arthur E. Attema, Marieke Krol, Job van Exel, Werner B. F. Brouwer
Do healthcare tax credits help poor-health individuals on low incomes?
Cinzia Di Novi, Anna Marenzi, Dino Rizzi